SCHEMBL5458375

SCHEMBL5458375

CCOc1cccc(NC(=O)Nc2ccc(C3=CCN(C(=O)OC(C)(C)C)CC3)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 4/20 0.58
WNT3A P56704 1/20 0.48
EPHX2 P34913 5/20 0.46
PDK4 Q16654 1/20 0.46
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MITF O75030 1/20 0.44
PAX8 Q06710 1/20 0.44
MAPT P10636 2/20 0.43
CDK7 P50613 1/20 0.43
CDK13 Q14004 1/20 0.43
CDK12 Q9NYV4 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5549910 0.88 NPC1 (0.50) NAMPTEPHX2NPC1RAB9ASMN1; SMN2
SCHEMBL5473484 0.83 NAMPT (0.62) NAMPTWNT3APDK4CDK7CDK13
SCHEMBL5465678 0.81 ESR2 (0.53) NAMPTEPHX2NPC1RAB9ACASP3
SCHEMBL5456796 0.81 NAMPT (0.56) NAMPTEPHX2NPC1RAB9ASMN1; SMN2
SCHEMBL5465641 0.80 NAMPT (0.58) NAMPTEPHX2NPC1RAB9ASMN1; SMN2
SCHEMBL5457909 0.79 MAPT (0.52) NAMPTEPHX2NPC1RAB9ASMN1; SMN2
SCHEMBL5458325 0.79 NAMPT (0.64) NAMPTPDK4NPC1RAB9ASMN1; SMN2
SCHEMBL22325022 0.78 NAMPT (0.71) NAMPTWNT3APDK4NPC1RAB9A
SCHEMBL31488923 0.78 NAMPT (0.68) NAMPTPDK4NPC1RAB9ASMN1; SMN2
SCHEMBL3987919 0.78 NAMPT (0.59) NAMPTWNT3APDK4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885WNT3A 3010/4885EPHX2 3683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.